Resveratrol treatment has neuroprotective effects and prevents cognitive impairment after chronic cerebral hypoperfusion

Neurological Research

Volumn 36, Issue 7, 2014, Pages 627-633

  Anastácio, Janine R ^a   Netto, Carlos A ^a   Castro, Cibele C ^a   Sanches, Eduardo F ^a   Ferreira, Daniele C ^b   Noschang, Cristie ^a   Krolow, Rachel ^a   Dalmaz, Carla ^a   Pagnussat, Aline ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Cerebral hypoperfusion; Cognitive function; Hippocampus; Resveratrol

Indexed keywords

NERVE GROWTH FACTOR; R 5010; RESVERATROL; UNCLASSIFIED DRUG; NEUROPROTECTIVE AGENT; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL OCCLUSION; BRAIN PERFUSION; CELL COUNTING; CELL STRUCTURE; CELL SURVIVAL; COGNITIVE DEFECT; CONTROLLED STUDY; EXPERIMENTAL BEHAVIORAL TEST; HIPPOCAMPAL CA1 REGION; HISTOLOGY; MALE; MORRIS WATER MAZE TEST; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; SPATIAL MEMORY; TASK PERFORMANCE; WORKING MEMORY; ANIMAL; BRAIN ISCHEMIA; CELL COUNT; COGNITION DISORDERS; DRUG EFFECTS; HIPPOCAMPUS; MAZE TEST; METABOLISM; NERVE CELL; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; SHORT TERM MEMORY; WISTAR RAT;

ANIMALS; BRAIN ISCHEMIA; CELL COUNT; COGNITION DISORDERS; HIPPOCAMPUS; MALE; MAZE LEARNING; MEMORY, SHORT-TERM; NERVE GROWTH FACTOR; NEURONS; NEUROPROTECTIVE AGENTS; NEUROPSYCHOLOGICAL TESTS; RANDOM ALLOCATION; RATS, WISTAR; SPATIAL MEMORY; STILBENES;

EID: 84902997869     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132813Y.0000000293     Document Type: Article

References (41)

1. Farkas E, Luiten PG, Bari F. Permanent, bilateral common carotid artery occlusion in the rat: a model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev. 2007;54:162-80.
2. Cechetti F, Worm PV, Pereira LO, Siqueira IR, Anetto C. The modified 2VO ischemia protocol causes cognitive impairment similar to that induced by the standard method, but with a better survival rate. Braz J Med Biol Res. 2010;43:1178-83.
3. Cechetti F, Pagnussat AS, Worm PV, Elsner VR, Ben J, da Costa MS, et al. Chronic brain hypoperfusion causes early glial activation and neuronal death, and subsequent long-term memory impairment. Brain Res Bull. 2012;87:109-16.
4. Chao XD, Fei F, Fei Z. The role of excitatory amino acid transporters in cerebral ischemia. Neurochem Res. 2010;35:1224-30.
5. Lau A, Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch. 2010;460:525-42.
6. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods. 1984;11:47-60.
7. Rypma B, D'Esposito M. Isolating the neural mechanisms of age-related changes in human working memory. Nat Neurosci. 2000;3:509-15.
8. Berry A, Bindocci E, Alleva E. NGF, brain and behavioral plasticity. Neural Plast. 2012;2012:784040.
9. Kidd PM. Integrated brain restoration after ischemic stroke - medical management, risk factors, nutrients, and other interventions for managing inflammation and enhancing brain plasticity. Altern Med Rev. 2009;14:14-35.
10. Alleva E, Petruzzi S, Cirulli F, Aloe L. NGF regulatory role in stress and coping of rodents and humans. Pharmacol Biochem Behav. 1996;54:65-72.
11. Manni L, Rocco ML, Bianchi P, Soligo M, Guaragna M, Barbaro SP, et al. Nerve growth factor: basic studies and possible therapeutic applications. Growth Factors. 2013;31:115-22.
12. Chiaretti A, Falsini B, Aloe L, Pierri F, Fantacci C, Riccardi R. Neuroprotective role of nerve growth factor in hypoxicischemic injury. From brain to skin. Arch Ital Biol. 2011;149:275-82.
13. Zhang F, Liu J, Shi JS. Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation. Eur J Pharmacol. 2010;636:1-7.
14. Mokni M, Elkahoui S, Limam F, Amri M, Aouani E. Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem Res. 2007;32:981-7.
15. Simao F, Matte A, Pagnussat AS, Netto CA, Salbego CG. Resveratrol preconditioning modulates inflammatory response in the rat hippocampus following global cerebral ischemia. Neurochem Int. 2012;61:659-65.
16. Sinha K, Chaudhary G, Gupta YK. Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci. 2002;71:655-65.
17. Lu KT, Chiou RY, Chen LG, Chen MH, Tseng WT, Hsieh HT, et al. Neuroprotective effects of resveratrol on cerebral ischemia-induced neuron loss mediated by free radical scavenging and cerebral blood flow elevation. J Agric Food Chem. 2006;54:3126-31.
18. Gao D, Zhang X, Jiang X, Peng Y, Huang W, Cheng G, et al. Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice. Life Sci. 2006;78:2564-70.
19. Netto CA, Hodges H, Sinden JD, Le Peillet E, Kershaw T, Sowinski P, et al. Effects of fetal hippocampal field grafts on ischaemic-induced deficits in spatial navigation in the water maze. Neuroscience. 1993;54:69-92.
20. Canal Castro C, Pagnussat AS, Orlandi L, Worm P, Moura N, Etgen AM, et al. Coumestrol has neuroprotective effects before and after global cerebral ischemia in female rats. Brain Res. 2012;1474:82-90.
21. Pagnussat AS, Michaelsen SM, Achaval M, Ilha J, Hermel EE, Back FP, et al. Effect of skilled and unskilled training on nerve regeneration and functional recovery. Braz J Med Biol Res. 2012;45:753-62.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193:265-75.
23. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5:493-506.
24. Simao F, Matte A, Pagnussat AS, Netto CA, Salbego CG. Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3beta and CREB through P13-K/Akt pathways. Eur J Neurosci. 2012;36:2899-905.
25. Farkas E, Institoris A, Domoki F, Mihaly A, Luiten PG, Bari F. Diazoxide and dimethyl sulphoxide prevent cerebral hypoperfusion-related learning dysfunction and brain damage after carotid artery occlusion. Brain Res. 2004;1008:252-60.
26. Ohtaki H, Fujimoto T, Sato T, Kishimoto K, Fujimoto M, Moriya M, et al. Progressive expression of vascular endothelial growth factor (VEGF) and angiogenesis after chronic ischemic hypoperfusion in rat. Acta Neurochir Suppl. 2006;96:283-7.
27. Farkas E, Donka G, de Vos RA, Mihaly A, Bari F, Luiten PG. Experimental cerebral hypoperfusion induces white matter injury and microglial activation in the rat brain. Acta Neuropathol. 2004;108:57-64.
28. Shin JA, Lee H, Lim YK, Koh Y, Choi JH, Park EM. Therapeutic effects of resveratrol during acute periods following experimental ischemic stroke. J Neuroimmunol. 2010;227:93-100.
29. Pagnussat AS, Simao F, Anastacio JR, Mestriner RG, Michaelsen SM, Castro CC, et al. Effects of skilled and unskilled training on functional recovery and brain plasticity after focal ischemia in adult rats. Brain Res. 2012;1486:53-61.
30. Yousuf S, Atif F, Ahmad M, Hoda N, Ishrat T, Khan B, et al. Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Res. 2009;1250:242-53.
31. Huang EJ, Reichardt LF. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci. 2001;24:677-736.
32. Ohab JJ, Fleming S, Blesch A, Carmichael ST. A neurovascular niche for neurogenesis after stroke. J Neurosci. 2006;26:13007-16.
33. Zacchigna S, Ruiz de Almodovar C, Carmeliet P. Similarities between angiogenesis and neural development: what small animal models can tell us. Curr Top Dev Biol. 2008;80:1-55.
34. Moser KV, Reindl M, Blasig I, Humpel C. Brain capillary endothelial cells proliferate in response to NGF, express NGF receptors and secrete NGF after inflammation. Brain Res. 2004;1017:53-60.
35. Simao F, Pagnussat AS, Seo JH, Navaratna D, Leung W, Lok J, et al. Pro-angiogenic effects of resveratrol in brain endothelial cells: nitric oxide-mediated regulation of vascular endothelial growth factor and metalloproteinases. J Cereb Blood Flow Metab. 2012;32:884-95.
36. Nico B, Mangieri D, Benagiano V, Crivellato E, Ribatti D. Nerve growth factor as an angiogenic factor. Microvasc Res. 2008;75:135-41.
37. Lee TH, Kato H, Chen ST, Kogure K, Itoyama Y. Expression of nerve growth factor and trkA after transient focal cerebral ischemia in rats. Stroke. 1998;29:1687-96; discussion 1697.
38. Oderfeld-Nowak B, Bacia A. Expression of astroglial nerve growth factor in damaged brain. Acta Neurobiol Exp (Wars). 1994;54:73-80.
39. Schmidt-Kastner R, Aguirre-Chen C, Saul I, Yick L, Hamasaki D, Busto R, et al. Astrocytes react to oligemia in the forebrain induced by chronic bilateral common carotid artery occlusion in rats. Brain Res. 2005;1052:28-39.
40. Marosi M, Rakos G, Robotka H, Nemeth H, Sas K, Kis Z, et al. Hippocampal (CA1) activities in Wistar rats from different vendors. Fundamental differences in acute ischemia. J Neurosci Methods. 2006;156:231-5.
41. Font MA, Arboix A, Krupinski J. Angiogenesis, neurogenesis and neuroplasticity in ischemic stroke. Curr Cardiol Rev. 2010;6:238-44.